Compounds > n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
Page last updated: 2024-08-24

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Multiple Sclerosis

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Multiple Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Beck, ES; Cortese, ICM; Dwyer, J; Koretsky, AP; McFarland, H; Nair, G; Ohayon, J; Reich, DS; Steele, SU; Sudarshana, DM; Suto, DJ1

Other Studies

1 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Multiple Sclerosis

ArticleYear
Manganese-Enhanced MRI in Patients with Multiple Sclerosis.
    AJNR. American journal of neuroradiology, 2020, Volume: 41, Issue:9

    Topics: Adult; Animals; Contrast Media; Edetic Acid; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Pilot Projects; Pyridoxal Phosphate

2020